Abstract Library

#3480 Is addition of NETest to clinical parameters valuable in the prognostication of patients with Small Intestinal Neuroendocrine Tumors (SI-NET)?

Introduction: A previously established nomogram based on clinical parameters was associated with disease specific survival (DSS) in patients with SI-NET, yet it underestimated DSS. (1,2)

Conference:

Presenting Author: Levy S

Authors: Levy S, van Treijen M, Tesselaar M, Valk G,

Keywords: SI-NET, Nomogram, NETest, DSS, PFS,

#3404 Defining disease status in gastroenteropancreatic neuroendocrine tumors: Choi criteria or RECIST?

Introduction: Adequate monitoring of changes in tumor load is fundamental for the assessment of disease evolution and response to treatment. There is an ongoing debate on the utility of RECIST v1.1 in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Conference:

Presenting Author:

Authors: van Treijen M, Schoevers J, Heeres B, van der Zee D, Maas M,

Keywords: treatment response, GEP-NET, imaging, surveillance,

#3402 Serial liquid biopsies - the NETest - in gastroenteropancreatic NET surveillance

Introduction: Current general biomarkers are insufficient to predict the disease course in individual patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).

Conference:

Presenting Author:

Authors: van Treijen M, Korse C, Verbeek W, Tesselaar M, Valk G,

Keywords: GEP-NET, disease status, prediction, treatment response, surveillance,

#2913 The Predictive Value of Neuroendocrine Transcript Analysis in Daily Practice: An Independent ‘Real-World’ Validation Study

Introduction: Assessment of disease status remains the fundamental basis in the management of gastro-entero-pancreatic neuro-endocrine tumors (GEPNETs). Circulating molecular information might be used as a liquid biopsy to predict its clinical course.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: van Treijen M

Authors: van Treijen M, van der Zee D, Heeres B, Staal F, Vriens M,

Keywords: biomarker, progression-free survival, gastro-entero-pancreatic neuroendocrine tumours,

#2748 CT-Based Radiomics for Prediction of Outcome after Somatostatin Analogues in Patients with Liver Metastases of a Neuroendocrine Tumor: An Exploratory Study

Introduction: Response evaluation and prediction of outcome of a neuroendocrine tumor (NET) remains difficult.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Staal F, Taghavi M, van Treijen M, Tesselaar M, Beets-Tan R,

Keywords: Radiomics, CT, Liver metastases, Response, Outcome prediction,